cancer immunotherapy

23andMe inches closes to cancer immunotherapy, guided by its genetic database
Pharma Voice
Tue, 08/20/24 - 10:28 am
23andMe
diagnostics
Medtech
cancer immunotherapy
drug discovery
Bristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer immunotherapy patent suits for $510M
Fierce Pharma
Tue, 08/1/23 - 12:02 pm
Bristol Myers Squibb
AstraZeneca
cancer immunotherapy
legal
patents
Patent Infringement
Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy
BioPharma Dive
Wed, 05/17/23 - 11:21 am
Siren Biotechnology
gene therapy
cancer immunotherapy
brain cancer
eye cancer
Moderna, Merck & Co. mRNA cancer vaccine slashes melanoma recurrence in Keytruda combo trial
Fierce Biotech
Tue, 12/13/22 - 10:35 am
Merck
Moderna Therapeutics
MRNA
cancer immunotherapy
Keytruda
melanoma
Jounce’s latest setback dampens outlook for another cancer immunotherapy target
BioPharma Dive
Tue, 08/30/22 - 06:10 pm
Jounce Therapeutics
lung cancer
cancer immunotherapy
vopratelimab
Merck study results signal blood cancer potential for new type of immunotherapy
BioPharma Dive
Thu, 05/26/22 - 10:40 pm
Merck
Bristol Myers Squibb
cancer
cancer immunotherapy
favezelimab
Hodgkin's lymphoma
Women see more adverse events with chemotherapy and newer cancer treatments, study finds
Stat
Mon, 03/7/22 - 10:18 am
women
cancer
chemotherapy
cancer immunotherapy
Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up?
Fierce Pharma
Sun, 10/3/21 - 08:27 pm
cancer
oncology
cancer immunotherapy
Merck
AstraZeneca
Regeneron
Sanofi
Asher Bio’s encouraging early data against rival cancer drug sparks $108M financing
MedCity News
Wed, 09/1/21 - 10:54 am
Asher Bio
funding
immunotherapy
cancer immunotherapy
Biotech IPO wave rolls on as Werewolf, Vaccitech raise $230M for clinical trials
MedCity News
Sun, 05/2/21 - 10:16 pm
Werewolf Therapeutics
Vaccitech
IPOs
cancer immunotherapy
vaccines
A look ahead at the FDA meeting that could decide the future of 6 cancer drug approvals
BioPharma Dive
Thu, 04/22/21 - 11:52 pm
FDA
cancer immunotherapy
Merck
Roche
Bristol Myers Squibb
AstraZeneca
Exscientia starts trials of first AI-derived cancer immunotherapy
Pharmaforum
Mon, 04/12/21 - 10:31 am
Exscientia
cancer immunotherapy
artificial intelligence
Achilles Therapeutics’ IPO nabs $175M to bring cell therapies to solid tumors
MedCity News
Thu, 04/1/21 - 10:47 am
Achilles Therapeutics
IPOs
cancer immunotherapy
Asher Raises $55 Million Series A for Targeted Cancer Immunotherapies
BioSpace
Tue, 03/23/21 - 11:24 pm
Asher Bio
cancer immunotherapy
Asher Bio adds $55M and takes a page from nature for cancer immunotherapy
MedCity News
Tue, 03/23/21 - 10:27 am
Interluekin-2
Asher Bio
cancer
cancer immunotherapy
AbbVie has 47 reasons for its $2B cancer immunotherapy partnership with I-Mab
MedCity News
Sun, 09/6/20 - 07:19 pm
AbbVie
I-Mab Biopharma
Forty Seven
lemzoparlimab
cancer immunotherapy
Can This Biotech Shed New Light on Cancer Immunotherapies?
Motley Fool
Mon, 05/4/20 - 10:29 pm
cancer immunotherapy
CompuGen
COM701
First patient dosed with Transgene’s TG6002 in colorectal cancer with liver metastases
Pharmaceutical Business Review
Fri, 02/21/20 - 10:30 am
Transgene
TG6002
cancer immunotherapy
colorectal cancer
clinical trials
France's Enterome Teams Up with Cancer Center to Validate Immunotherapy Candidate
BioSpace
Thu, 11/7/19 - 10:54 pm
Enterome
Memorial Sloan Kettering
microbiome
cancer immunotherapy
3 Companies To Watch For At November’s Society for Immunotherapy of Cancer Meeting
Motley Fool
Wed, 10/9/19 - 10:25 am
SITC
cancer immunotherapy
Autolus Therapeutics
Mirati Therapeutics
Nektar Therapeutics

Pages